Pharmaceuticals

Fast Melt Tablets Market Size Forecast: Revenue and CAGR by 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Fast Melt Tablets Industry Expected To Reach By 2029, Starting From 2025 Levels?

The fast melt tablets market size has seen significant growth in recent years. It is anticipated to increase from $4.96 billion in 2024 to $5.33 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.5%. Historically, this growth can be attributed to an expanding geriatric population, a rise in chronic illnesses, evolving self-medication trends, the broadening pharmaceutical sector, and an increase in disposable income.

The fast melt tablets market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $7.18 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.7%. This projected growth is driven by factors such as the increasing incidence of dysphagia, a growing preference for OTC drugs, wider e-commerce penetration, escalating demand for oral dissolving drugs, and improvements in healthcare infrastructure. Key trends anticipated during this forecast period encompass technological advancements, novel formulation techniques, the integration of nanotechnology, a movement towards plant-based excipients, and the adoption of smart drug delivery systems.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23398&type=smp

What Are The Drivers Pushing New Developments In The Fast Melt Tablets Market?

The increasing occurrence of heart attacks is anticipated to drive the expansion of the fast melt tablets market in the future. A heart attack is defined as a critical medical event resulting from an obstruction of blood flow to the heart muscle, typically caused by a blood clot or accumulation of plaque within the coronary arteries. The frequency of heart attacks is escalating, attributed to greater intake of processed foods, which contributes to elevated cholesterol and the formation of arterial plaque. Fast melt tablets offer quick drug absorption, facilitating the faster administration of essential medications like aspirin or nitroglycerin. This helps avert additional harm during a heart attack, enhancing patient recovery by re-establishing blood flow and diminishing the likelihood of serious complications. For example, data from January 2024, published by the British Heart Foundation, a UK-based cardiovascular research charity, indicated that in 2022, over 39,000 individuals in England experienced premature deaths from cardiovascular diseases including heart attacks, coronary heart disease, and stroke, amounting to an average of 750 deaths per week. This figure represents the highest recorded total. Consequently, the increasing prevalence of heart attacks is fueling the expansion of the fast melt tablets market.

What Are The Primary Types Of Segments Analyzed In The Fast Melt Tablets Market?

The fast melt tablets market covered in this report is segmented –

1) By Type: Anti Psychotics, Anti Epileptics, Central Nervous System (CNS) Stimulants, Anxiolytics, Anti Parkinsonian Drugs, Anti Hypertensive, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Anti Allergy Drugs, Proton Pump Inhibitors, Other Types

2) By Indication: Pain Management, Allergy And Respiratory Disorders, Neurological Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Other Indications

3) By Dosage Form: Oral, Sublingual, Buccal, Chewable

4) By Age Group: Adult, Pediatrics, Geriatrics

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By Anti Psychotics: Atypical Antipsychotics, Typical Antipsychotics

2) By Anti Epileptics: Sodium Channel Blockers, Gamma-Aminobutyric Acid (GABA) Analogs, Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (AMPA) Receptor Antagonists, Carbonic Anhydrase Inhibitors

3) By Central Nervous System (CNS) Stimulants: Amphetamines, Methylphenidate, Modafinil, Xanthine Derivatives

4) By Anxiolytics: Benzodiazepines, Azapirones, Barbiturates, Antihistamines

5) By Anti Parkinsonian Drugs: Dopamine Agonists, Monoamine Oxidase-B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT) Inhibitors, Anticholinergics

6) By Anti Hypertensive: Beta Blockers, Calcium Channel Blockers, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics

7) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDS): Cyclooxygenase-1 (COX-1) Inhibitors, Cyclooxygenase-2 (COX-2) Inhibitors

8) By Anti Allergy Drugs: Antihistamines, Leukotriene Receptor Antagonists, Mast Cell Stabilizers, Corticosteroids

9) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole

10) By Other Types: Antiemetics, Antidepressants, Muscle Relaxants, Analgesics

How Are Trends Influencing The Fast Melt Tablets Market?

Major companies within the fast melt tablets market are prioritizing the development of innovative products, such as rapidly dissolving tablets, to improve patient convenience and accelerate drug absorption. Rapidly dissolving tablets (RDTs) are solid dosage forms engineered to disintegrate quickly in the mouth without requiring water. As an illustration, in December 2022, Melt Pharmaceuticals, a US-based clinical-stage pharmaceutical company, launched Melt 300, a sophisticated fast-melting tablet formulation designed for efficient sedation. This innovative sublingual fast-melting tablet, which combines midazolam (3 mg) and ketamine (50 mg), dissolves quickly, ensuring a rapid onset and effective sedation without the necessity of intravenous administration. Targeting the expanding demand for needle-free, patient-friendly sedation options, Melt 300 enhances procedural comfort while streamlining clinical workflows.

Who Are The Primary Competitors In The Global Fast Melt Tablets Market?

Major companies operating in the fast melt tablets market are Pfizer Inc., Johnson & Johnson, Fuji Chemical Industries Co. Ltd., Teva Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Sun Pharmaceutical Industries Ltd, Catalent Inc., Aurobindo Pharma Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Centrient Pharmaceuticals B.V., Lannett Company Inc., Unichem Laboratories Ltd., SPI Pharma Inc., Windmill Health Products LLC, The Procter & Gamble Company, Perrigo Company plc, Melt Pharmaceuticals Inc., Imodium, Calpol, Akina Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/fast-melt-tablets-global-market-report

Which Geographies Are Emerging As Strong Markets For The Fast Melt Tablets Industry?

North America was the largest region in the fast melt tablets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fast melt tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Fast Melt Tablets Market Report:

https://www.thebusinessresearchcompany.com/customise?id=23398&type=smp

Browse Through More Reports Similar to the Global Fast Melt Tablets Market 2025, By The Business Research Company

Fast Fashion Market 2025

https://www.thebusinessresearchcompany.com/report/fast-fashion-market

Fast Food And Quick Service Restaurant Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fast-food-and-quick-service-restaurant-global-market-report

Fast Attack Craft Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fast-attack-craft-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795